Department of Medicine, Unit of Endocrinology and Diabetes, University Campus Bio-Medico of Rome, Rome, Italy.
Centre of Immunobiology, Barts and The London School of Medicine, Queen Mary, University of London, London, UK.
Diabetes Metab Res Rev. 2016 Jul;32(5):438-9. doi: 10.1002/dmrr.2825.
More than one quarter of people affected by type 2 diabetes worldwide live in China, where an alarming increase in diabetes incidence is taking place. However, most of the evidence about diabetes management derives from studies conducted on non-Asian people, raising concerns about their validity in other ethnic groups, including the Chinese. The guidelines proposed by the Chinese Diabetes Society suggest tools for medical doctors in China and worldwide to appropriately face diabetes in Chinese people, whose number in non-Chinese countries is continuously increasing. However, additional efforts are still needed to achieve an evidence-based tailored therapy for type 2 diabetes in Chinese people. Copyright © 2016 John Wiley & Sons, Ltd.
全球超过四分之一的 2 型糖尿病患者生活在中国，中国的糖尿病发病率正呈惊人上升趋势。然而，大多数关于糖尿病管理的证据都来自于非亚洲人群的研究，这让人担心这些证据在其他种族群体（包括中国人）中的有效性。中国糖尿病学会提出的指南为中国和世界各地的医生提供了工具，以帮助他们恰当地应对中国人的糖尿病问题，因为在非中国国家的中国人数量正在不断增加。然而，仍需要做出更多努力，为中国人的 2 型糖尿病制定基于证据的个体化治疗方案。版权所有 © 2016 年 John Wiley & Sons, Ltd.
